Yttrium-90-labelled somatostatin-analogue for cancer treatment

Lancet. 1998 Feb 7;351(9100):417-8. doi: 10.1016/s0140-6736(05)78355-0.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuroendocrine Tumors / chemistry
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / radiotherapy*
  • Octreotide / analogs & derivatives*
  • Octreotide / therapeutic use
  • Radiopharmaceuticals / therapeutic use*
  • Receptors, Somatostatin / analysis
  • Yttrium Radioisotopes / therapeutic use*

Substances

  • Radiopharmaceuticals
  • Receptors, Somatostatin
  • Yttrium Radioisotopes
  • Octreotide
  • Edotreotide